Amarin | AMRN - Trade Creditors

Stock Price
14.66
Daily Change
-0.08 -0.54%
Monthly
0.55%
Yearly
79.66%
Q2 Forecast
14.28

Amarin reported $45.36M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Alnylam Pharmaceuticals USD 115.72M 1.87M Dec/2025
Amarin USD 45.36M 8.64M Dec/2025
AstraZeneca USD 25.28B 252M Dec/2025
BioCryst Pharmaceuticals USD 15.83M 10.26M Dec/2025
DBV Technologies USD 39.82M 972K Sep/2025
Esperion Therapeutics USD 65.07M 12.44M Dec/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Halozyme Therapeutics USD 20.9M 5.54M Dec/2025
Heron Therapeutics USD 8.99M 3.02M Dec/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Neurocrine Biosciences USD 545.5M 425.6M Dec/2025
Novartis USD 4.46B 99M Dec/2025